MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell

BACKGROUND: One of the major obstacles in the treatment of breast cancer is breast cancer stem cells (BCSC) which are resistant to standard chemotherapeutic drugs. It has been proven that microRNA-200c (miR-200c) can restore sensitivity to microtubule-targeting chemotherapeutic drugs by reducing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingwen, Meng, Tingting, Yuan, Ming, Wen, Lijuan, Cheng, Bolin, Liu, Na, Huang, Xuan, Hong, Yun, Yuan, Hong, Hu, Fuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161334/
https://www.ncbi.nlm.nih.gov/pubmed/28003747
http://dx.doi.org/10.2147/IJN.S111647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161334/
https://www.ncbi.nlm.nih.gov/pubmed/28003747
http://dx.doi.org/10.2147/IJN.S111647

Ejemplares similares